rs140360713
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4BS1_Supporting
The NM_033409.4(SLC52A3):c.1381G>T(p.Asp461Tyr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000627 in 1,609,324 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_033409.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000256 AC: 39AN: 152236Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000377 AC: 89AN: 236074Hom.: 0 AF XY: 0.000362 AC XY: 47AN XY: 129686
GnomAD4 exome AF: 0.000666 AC: 970AN: 1456970Hom.: 1 Cov.: 30 AF XY: 0.000646 AC XY: 468AN XY: 724526
GnomAD4 genome AF: 0.000256 AC: 39AN: 152354Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74498
ClinVar
Submissions by phenotype
not provided Uncertain:3
- -
Identified in two patients in the published literature with a second SLC52A3 variant with gait disturbance, muscle weakness, and hearing loss who both demonstrated improvement upon use of riboflavin therapy (PMID: 27777325, Marques et al., 2024); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 34662687, 27777325, 23506902, Marques2024[CaseReport], 33087424, 37845732, 38974615) -
- -
Brown-Vialetto-van Laere syndrome 1 Uncertain:2
This sequence change replaces aspartic acid, which is acidic and polar, with tyrosine, which is neutral and polar, at codon 461 of the SLC52A3 protein (p.Asp461Tyr). This variant is present in population databases (rs140360713, gnomAD 0.07%). This missense change has been observed in individual(s) with clinical features of Brown-Vialetto-Van Laere syndrome (PMID: 27777325; Invitae). ClinVar contains an entry for this variant (Variation ID: 476604). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SLC52A3 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
Inborn genetic diseases Uncertain:1
The c.1381G>T (p.D461Y) alteration is located in exon 5 (coding exon 4) of the SLC52A3 gene. This alteration results from a G to T substitution at nucleotide position 1381, causing the aspartic acid (D) at amino acid position 461 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at